Neuropsychological Outcomes After Stereo-EEG Radiofrequency Thermocoagulation.

IF 7.7 1区 医学 Q1 CLINICAL NEUROLOGY Neurology Pub Date : 2024-12-10 Epub Date: 2024-11-18 DOI:10.1212/WNL.0000000000209815
Emily Cockle, Charles B Malpas, Honor Coleman, Alissandra McIlroy, Joshua Laing, Patrick Kwan, Martin Hunn, Matthew Gutman, Cecilia Harb, Cathermine Meade, Wendyl J D'Souza, Amy J Halliday, Kristian Bulluss, Simon J Vogrin, Rubina Alpitsis, Terence J O'Brien, Genevieve Rayner, Andrew Neal
{"title":"Neuropsychological Outcomes After Stereo-EEG Radiofrequency Thermocoagulation.","authors":"Emily Cockle, Charles B Malpas, Honor Coleman, Alissandra McIlroy, Joshua Laing, Patrick Kwan, Martin Hunn, Matthew Gutman, Cecilia Harb, Cathermine Meade, Wendyl J D'Souza, Amy J Halliday, Kristian Bulluss, Simon J Vogrin, Rubina Alpitsis, Terence J O'Brien, Genevieve Rayner, Andrew Neal","doi":"10.1212/WNL.0000000000209815","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Stereo-EEG-guided radiofrequency thermocoagulation (RFTHC) has been proposed as relatively safe from a cognitive perspective; however, there is a lack of evidence based on neuropsychological assessments supporting this. This study is the first prospective evaluation of neuropsychological outcomes associated with stereo-EEG-guided RFTHC in patients with focal drug-resistant epilepsy.</p><p><strong>Methods: </strong>This cohort study involved prospective recruitment of consecutive patients undergoing stereo-EEG from 2 Australian centers. A comprehensive neuropsychological assessment was administered before implantation and 3 months after RFTHC (M = 104.51 days, SD = 29.25). Outcomes across cognitive domains were assessed at a group level with repeated measures <i>t</i> tests. Factorial repeated measures analyses of variance compared memory and language outcomes according to whether dominant mesial temporal lobe (mTL) structures were coagulated. Reliable change indices (RCIs) were computed to explore psychometrically reliable changes at an individual level.</p><p><strong>Results: </strong>The sample comprised 39 patients who underwent stereo-EEG (M = 37.08 ± 9.67 years, range = 17-56 years, 54% female). Nineteen (49%) had a language dominant epileptogenic zone (EZ), 16 (41%) a nondominant EZ, and 4 (10%) a bilateral EZ. All patients underwent RFTHC with a mean of 11.87 (SD = 6.82, range = 2-29) coagulation sites. Ten patients (26%) had RFTHC within the dominant mTL. At a group level, RFTHC was not associated with a significant decline on any neuropsychological measures (all comparisons <i>p</i> > 0.05). Subgroup analyses revealed a decline in delayed verbal recall after RFTHC of dominant mTL structures (<i>F</i>(1,37) = 4.46, <i>p</i> = 0.04, η<sub>p</sub><sup>2</sup> = 0.11, 95% CI [0-0.30]; medium to large effect), although it did not remain statistically significant after correction for false discovery rate. No statistically significant group differences were observed on visual memory or language measures post-RFTHC (all comparisons <i>p</i> > 0.05). RCI revealed that after RFTHC within the dominant mTL, 20% of patients experienced a decline in verbal memory and 10% in visual memory. By contrast, 7% declined in verbal memory and 10% in visual memory post-RFTHC outside the dominant mTL.</p><p><strong>Discussion: </strong>While these findings support the current view that RFTHC is cognitively benign for most cases, the results raise the question of a verbal memory decline after coagulation of the dominant mTL. Individualized neuropsychological counseling before stereo-EEG is essential to avoid unanticipated deficits.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"103 11","pages":"e209815"},"PeriodicalIF":7.7000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000209815","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Stereo-EEG-guided radiofrequency thermocoagulation (RFTHC) has been proposed as relatively safe from a cognitive perspective; however, there is a lack of evidence based on neuropsychological assessments supporting this. This study is the first prospective evaluation of neuropsychological outcomes associated with stereo-EEG-guided RFTHC in patients with focal drug-resistant epilepsy.

Methods: This cohort study involved prospective recruitment of consecutive patients undergoing stereo-EEG from 2 Australian centers. A comprehensive neuropsychological assessment was administered before implantation and 3 months after RFTHC (M = 104.51 days, SD = 29.25). Outcomes across cognitive domains were assessed at a group level with repeated measures t tests. Factorial repeated measures analyses of variance compared memory and language outcomes according to whether dominant mesial temporal lobe (mTL) structures were coagulated. Reliable change indices (RCIs) were computed to explore psychometrically reliable changes at an individual level.

Results: The sample comprised 39 patients who underwent stereo-EEG (M = 37.08 ± 9.67 years, range = 17-56 years, 54% female). Nineteen (49%) had a language dominant epileptogenic zone (EZ), 16 (41%) a nondominant EZ, and 4 (10%) a bilateral EZ. All patients underwent RFTHC with a mean of 11.87 (SD = 6.82, range = 2-29) coagulation sites. Ten patients (26%) had RFTHC within the dominant mTL. At a group level, RFTHC was not associated with a significant decline on any neuropsychological measures (all comparisons p > 0.05). Subgroup analyses revealed a decline in delayed verbal recall after RFTHC of dominant mTL structures (F(1,37) = 4.46, p = 0.04, ηp2 = 0.11, 95% CI [0-0.30]; medium to large effect), although it did not remain statistically significant after correction for false discovery rate. No statistically significant group differences were observed on visual memory or language measures post-RFTHC (all comparisons p > 0.05). RCI revealed that after RFTHC within the dominant mTL, 20% of patients experienced a decline in verbal memory and 10% in visual memory. By contrast, 7% declined in verbal memory and 10% in visual memory post-RFTHC outside the dominant mTL.

Discussion: While these findings support the current view that RFTHC is cognitively benign for most cases, the results raise the question of a verbal memory decline after coagulation of the dominant mTL. Individualized neuropsychological counseling before stereo-EEG is essential to avoid unanticipated deficits.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
立体电子脑电图射频热凝术后的神经心理学结果
背景和目的:从认知角度来看,立体电子脑电图引导下射频热凝术(RFTHC)被认为是相对安全的;然而,目前还缺乏基于神经心理学评估的证据来支持这一观点。本研究是首次对局灶性耐药性癫痫患者在立体EEG引导下接受RFTHC治疗的神经心理学结果进行前瞻性评估:这项队列研究从澳大利亚的两个中心招募了连续接受立体脑电图治疗的患者。在植入前和 RFTHC 术后 3 个月(M = 104.51 天,SD = 29.25)进行了全面的神经心理学评估。通过重复测量 t 检验对各组认知领域的结果进行评估。根据颞叶中叶(mTL)结构是否凝固,对记忆和语言结果进行了因子重复测量方差分析。计算可靠变化指数(RCIs),以探讨个体水平上心理统计学上的可靠变化:样本包括 39 名接受立体电子脑电图检查的患者(M = 37.08 ± 9.67 岁,年龄范围 = 17-56 岁,54% 为女性)。19人(49%)有语言优势致痫区(EZ),16人(41%)有非优势致痫区,4人(10%)有双侧致痫区。所有患者都接受了 RFTHC,凝固部位平均为 11.87 个(标度 = 6.82,范围 = 2-29)。10名患者(26%)在显性mTL内进行了RFTHC。在群体水平上,RFTHC 与任何神经心理学指标的显著下降均无关联(所有比较 p > 0.05)。亚组分析显示,在显性 mTL 结构的 RFTHC 后,延迟言语回忆能力下降(F(1,37) = 4.46,p = 0.04,ηp2 = 0.11,95% CI [0-0.30];中至大效应),尽管在校正错误发现率后,延迟言语回忆能力并不具有统计学意义。在 RFTHC 后的视觉记忆或语言测量方面,没有观察到有统计学意义的组间差异(所有比较 p > 0.05)。RCI 显示,在显性 mTL 内进行 RFTHC 治疗后,20% 的患者言语记忆下降,10% 的患者视觉记忆下降。相比之下,在显性磁层外进行 RFTHC 治疗后,7% 的患者言语记忆力下降,10% 的患者视觉记忆力下降:讨论:虽然这些研究结果支持目前的观点,即 RFTHC 对大多数病例的认知是良性的,但结果提出了在显性 mTL 凝血后言语记忆力下降的问题。为避免出现意料之外的缺陷,在进行立体电子脑电图检查前进行个性化的神经心理学咨询至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurology
Neurology 医学-临床神经学
CiteScore
12.20
自引率
4.00%
发文量
1973
审稿时长
2-3 weeks
期刊介绍: Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology. As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content. Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.
期刊最新文献
Clinical Reasoning: A 65-Year-Old Woman With Isolated Macroglossia as the Initial Presentation of a Rare Disease. Eculizumab in AQP4-IgG NMOSD: Efficacy in the Real World and Potential Warning of Meningococcal Vaccines. Moving Things Along: A New Model for the NINDS Clinical Neurotherapeutic Pipeline. Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD. Teaching NeuroImage: Occipital Condyle Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1